Document Detail


Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization.
MedLine Citation:
PMID:  9860115     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The mesoaccumbens dopamine (DA) system is intricately involved in sensitization to the locomotor stimulant effects of cocaine. Among the adaptations implicated in cocaine sensitization are transient subsensitivity of impulse-regulating DA D2 autoreceptors on ventral tegmental area (VTA) DA neurons leading to hyperactivity of the mesoaccumbens DA pathway, and persistently enhanced DA D1 receptor responses of nucleus accumbens (NAc) neurons. We have tested the hypothesis that both of these adaptations are necessary to produce cocaine sensitization. We injected rats twice daily for 2 weeks with the selective DA D1 class receptor agonist SKF 38393, the DA D2 class receptor agonist quinpirole, or both. We then used single-cell recording procedures to determine possible alterations in VTA DA autoreceptor sensitivity and NAc D1 receptor sensitivity at three withdrawal times: 1 day, 1 week and 1 month. We also tested whether these treatments produced cross-sensitization to cocaine at each withdrawal time. Repeated quinpirole treatment produced a reduction in VTA autoreceptor sensitivity and cross-sensitization to cocaine, but these effects lasted for less than 1 week. Repeated SKF 38393 treatment produced enhanced NAc D1 responses which lasted for 1 week and cross-sensitization to cocaine which was only evident after 1 week of withdrawal. Repeated treatment with the combination of the two agonists transiently down-regulated autoreceptor sensitivity, enhanced and prolonged D1 receptor supersensitivity (lasting 1 month), and produced enduring cross-sensitization to cocaine. These results suggest that neuroadaptations within both the VTA and NAc may be necessary for the induction of enduring cocaine sensitization.
Authors:
D J Henry; X T Hu; F J White
Related Documents :
20143275 - Differential sensitivity of a2a and especially d2 receptor trafficking to cocaine compa...
12399005 - Effects of the selective mu(1)-opioid receptor antagonist, naloxonazine, on cocaine-ind...
11322955 - Pharmacological properties of the mouse neurotensin receptor 3. maintenance of cell sur...
24666365 - Nociceptin/orphanin fq peptide receptor antagonist jtc-801 reverses pain and anxiety sy...
1330075 - Anisodamine antagonizes acetylcholine-induced inhibition of adrenergic neurotransmissio...
1656025 - Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for dif...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Psychopharmacology     Volume:  140     ISSN:  0033-3158     ISO Abbreviation:  Psychopharmacology (Berl.)     Publication Date:  1998 Nov 
Date Detail:
Created Date:  1999-02-25     Completed Date:  1999-02-25     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7608025     Medline TA:  Psychopharmacology (Berl)     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  233-42     Citation Subset:  IM    
Affiliation:
Department of Cellular and Molecular Pharmacology, Finch University of Health Sciences, The Chicago Medical School, North Chicago, IL 60064-3095, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
Animals
Autoreceptors / drug effects,  physiology
Cocaine / pharmacology*
Male
Nucleus Accumbens / drug effects,  physiology*
Quinpirole / pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Dopamine D1 / agonists,  physiology*
Receptors, Dopamine D2 / agonists,  physiology*
Ventral Tegmental Area / drug effects,  physiology*
Grant Support
ID/Acronym/Agency:
DA-00207/DA/NIDA NIH HHS; DA-04093/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Autoreceptors; 0/Receptors, Dopamine D1; 0/Receptors, Dopamine D2; 50-36-2/Cocaine; 67287-49-4/2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 85760-74-3/Quinpirole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Excitotoxic lesions of the mediodorsal thalamic nucleus attenuate intravenous cocaine self-administr...
Next Document:  5-HT3 receptor over-expression decreases ethanol self administration in transgenic mice.